In addition to the weekly specialist Neuromuscular and Motor Neuron Disease clinics and regular education sessions offered by the Adult Neuromuscular Team at Southmead Hospital, and as part of the ...

New research at the University of Alberta may make it easier to diagnose serious diseases that disrupt the body's energy ...

Our faculty expertise and institutional resources cover all aspects of adult and pediatric neuromuscular disease. Opportunities exist to participate in intramural or extramurally funded basic, ...

In a small human trial in SMA patients neurostimulation sessions improved motoneuron function, reduced fatigue, and improved leg muscle strength and walking.

A new drug-free, minimally invasive intervention targets the root cause of progressive loss of neural function in spinal ...

The fellow will participate in the General Neuromuscular Clinic, the Muscle Disease Center Clinic (a Multidisciplinary Clinic of adults and children with muscular dystrophies and other neuromuscular ...

MDA launches 75th Anniversary campaign and premieres new public service announcement (PSA) to mark 75 years of impact in the neuromuscular disease community. Pictured, Matt Plummer, MDA Board member ...

Lupin and Avas launch NaMuscla in Italy to treat myotonia in adults with NDM disorders: Our Bureau, Mumbai Tuesday, January 28, 2025, 16:45 Hrs [IST] Global pharma major Lupin Lim ...

Global pharma major Lupin Limited (Lupin) and Avas Pharmaceuticals SRL (Avas) today announced the launch of Lupin’s orphan drug NaMuscla® (mexiletine) in Italy. Avas will commercialize NaMuscla® for ...